Target
Ephrin type-A receptor 2
Ligand
BDBM50551198
Substrate
n/a
Meas. Tech.
ChEMBL_2030715 (CHEMBL4684873)
IC50
2700±n/a nM
Citation
 Incerti, MRusso, SCorrado, MGiorgio, CBallabeni, VChiodelli, PRusnati, MScalvini, LCallegari, DCastelli, RVacondio, FFerlenghi, FTognolini, MLodola, A Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3?-carbamoyloxy derivative with antiangiogenetic properties. Eur J Med Chem 189:0 (2020) [PubMed]  Article 
Target
Name:
Ephrin type-A receptor 2
Synonyms:
2.7.10.1 | EPHA2_MOUSE | Eck | Epha2 | Ephrin type-A receptor 2 | Epithelial cell kinase | Myk2 | Sek2 | Tyrosine-protein kinase receptor ECK | Tyrosine-protein kinase receptor MPK-5 | Tyrosine-protein kinase receptor SEK-2
Type:
PROTEIN
Mol. Mass.:
108847.01
Organism:
Mus musculus
Description:
ChEMBL_117464
Residue:
977
Sequence:
MELRAVGFCLALLWGCALAAAAAQGKEVVLLDFAAMKGELGWLTHPYGKGWDLMQNIMDDMPIYMYSVCNVVSGDQDNWLRTNWVYREEAERIFIELKFTVRDCNSFPGGASSCKETFNLYYAESDVDYGTNFQKRQFTKIDTIAPDEITVSSDFEARNVKLNVEERMVGPLTRKGFYLAFQDIGACVALLSVRVYYKKCPEMLQSLARFPETIAVAVSDTQPLATVAGTCVDHAVVPYGGEGPLMHCTVDGEWLVPIGQCLCQEGYEKVEDACRACSPGFFKSEASESPCLECPEHTLPSTEGATSCQCEEGYFRAPEDPLSMSCTRPPSAPNYLTAIGMGAKVELRWTAPKDTGGRQDIVYSVTCEQCWPESGECGPCEASVRYSEPPHALTRTSVTVSDLEPHMNYTFAVEARNGVSGLVTSRSFRTASVSINQTEPPKVRLEDRSTTSLSVTWSIPVSQQSRVWKYEVTYRKKGDANSYNVRRTEGFSVTLDDLAPDTTYLVQVQALTQEGQGAGSKVHEFQTLSTEGSANMAVIGGVAVGVVLLLVLAGVGLFIHRRRRNLRARQSSEDVRFSKSEQLKPLKTYVDPHTYEDPNQAVLKFTTEIHPSCVARQKVIGAGEFGEVYKGTLKASSGKKEIPVAIKTLKAGYTEKQRVDFLSEASIMGQFSHHNIIRLEGVVSKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIASGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSYGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERSRRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPSTSGSEGVPFRTVSEWLESIKMQQYTEHFMVAGYTAIEKVVQMSNEDIKRIGVRLPGHQKRIAYSLLGLKDQVNTVGIPI
  
Inhibitor
Name:
BDBM50551198
Synonyms:
CHEMBL4783384
Type:
Small organic molecule
Emp. Form.:
C31H51NO4
Mol. Mass.:
501.7409
SMILES:
[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)OC(=O)NC1CCCCC1)[C@H](C)CCC(O)=O |r|
Structure:
Search PDB for entries with ligand similarity: